Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.95 |
| ▸ | GMNN | O75496 | 1/20 | 0.95 |
| ▸ | LMNA | P02545 | 1/20 | 0.95 |
| ▸ | MAPT | P10636 | 1/20 | 0.95 |
| ▸ | BLM | P54132 | 1/20 | 0.95 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.95 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.95 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | SHBG | P04278 | 1/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4078170 | 1.00 | TP53 (1.00) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL23270700 | 1.00 | TP53 (1.00) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL5228082 | 1.00 | TP53 (1.00) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL4079339 | 1.00 | TP53 (1.00) | TP53KDM4EGMNNLMNAMAPT | |
| Hydrochloric Acid SCHEMBL160732 | 0.97 | KDM4E (1.00) | TP53KDM4EGMNNLMNAMAPT | |
| Hydrochloric Acid SCHEMBL2063394 | 0.97 | KDM4E (1.00) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL3647508 | 0.97 | — | — | |
| SCHEMBL22535894 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL19642704 | 0.95 | KDM4E (0.95) | TP53KDM4EGMNNLMNAMAPT | |
| Hydrochloric Acid SCHEMBL30187467 | 0.95 | KDM4E (0.95) | TP53KDM4EGMNNLMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 341 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116120554-A | Composition for optical lens material with high refractive index and low thermal expansion coefficient | 益丰新材料股份有限公司 | 2023-05-16 | — | — | CN | claimed |
| US-20210330606-A1 | GLUCOSE CONSUMPTION ACCELERATOR AND GLYCOLYSIS ACCELERATOR | SHINKO SANGYO CO., LTD. (JP) | 2021-10-28 | — | — | US | claimed |
| EP-3639818-B1 | GLUCOSE CONSUMPTION PROMOTER AND GLYCOLYSIS PROMOTER | SHINKO SANGYO CO LTD (JP) | 2021-07-07 | — | — | EP | claimed |
| CN-111093644-A | Glucose consumption promoter and glycolysis promoter | 株式会社亲广产业 | 2020-05-01 | — | — | CN | claimed |
| EP-3639818-A1 | GLUCOSE CONSUMPTION PROMOTER AND GLYCOLYSIS PROMOTER | Shinko Sangyo Co., Ltd. (JP) | 2020-04-22 | — | — | EP | claimed |
| WO-2020026471-A1 | GLUCOSE CONSUMPTION PROMOTER AND GLYCOLYSIS PROMOTER | 株式会社親広産業 | 2020-02-06 | — | — | WO | claimed |
| WO-2020026570-A1 | GLUCOSE CONSUMPTION PROMOTER AND GLYCOLYSIS PROMOTER | 株式会社親広産業 | 2020-02-06 | — | — | WO | claimed |
| US-10109428-B2 | Process to improve coverage and electrical performance of solid electrolytic capacitors | KEMET ELECTRONICS CORPORATION (US) | 2018-10-23 | — | — | US | claimed |
| US-20170338048-A1 | Process to Improve Coverage and Electrical Performance of Solid Electrolytic Capacitors | KEMET ELECTRONICS CORPORATION | 2017-11-23 | — | — | US | claimed |
| US-9761347-B2 | Process to improve coverage and electrical performance of solid electrolytic capacitor | KEMET ELECTRONICS CORPORATION (US) | 2017-09-12 | — | — | US | claimed |
| WO-2007101859-A1 | SUBSTITUTED PYRAZOLOPYRIMIDINES, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF FOR CONTROLLING PARASITIC FUNGI AND AGENTS CONTAINING THE LATTER | BASF SE (DE) | 2007-09-13 | — | — | WO | claimed |
| WO-2007101871-A1 | SUBSTITUTED IMIDAZOLOPYRIMIDINES, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF FOR CONTROLLING PARASITIC FUNGI AND AGENTS CONTAINING THE LATTER | BASF SE (DE) | 2007-09-13 | — | — | WO | claimed |
| EP-1501884-A1 | AMINO-FUNCTIONAL POLYSILOXANES AND THEIR USE IN COATINGS | SigmaKalon Services B.V. (NL) | 2005-02-02 | — | — | EP | claimed |
| WO-2003093352-A1 | AMINO-FUNCTIONAL POLYSILOXANES AND THEIR USE IN COATINGS | SIGMAKALON SERVICES B.V. (NL) | 2003-11-13 | — | — | WO | claimed |
| US-6316671-B1 | DISSOLVING RACEMIC MIXTURE WITH ENANTIOMORPH OF N-TOSYL-LEUCINE IN PURE ALCOHOL; ISOLATING LESS SOLUBLE CRYSTALLIZED SALT | UNIVERSITE DE ROUEN (FR) | 2001-11-13 | — | — | US | claimed |
| EP-0946467-A1 | METHOD FOR SPLITTING 1-AMINO-ALKAN-2-OL COMPOUNDS | UNIVERSITE DE ROUEN (FR) | 1999-10-06 | — | — | EP | claimed |
| WO-1998023559-A1 | METHOD FOR SPLITTING 1-AMINO-ALKAN-2-OL COMPOUNDS | UNIVERSITE DE ROUEN (FR) | 1998-06-04 | — | — | WO | claimed |
| US-4759861-A | Consists of an aliphatic mono- or di-carboxylic acid, a dimer or trimer of said dicarboxylic acid, petroleum sulfonic acid and naphthenic acid or salt | NIPPON OIL CO., LTD. (JP) | 1988-07-26 | — | — | US | claimed |
| US-4011311-A | GELS, DEODORANTS, ADHESIVES | AKZO N.V. (NL) | 1977-03-08 | — | — | US | claimed |
| US-3968104-A | SOLVENTS | BAYER AKTIENGESELLSCHAFT (DT) | 1976-07-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210330606-A1 | GLUCOSE CONSUMPTION ACCELERATOR AND GLYCOLYSIS ACCELERATOR | SLC2A1, SLC2A2, SLC2A8 | TP53 3344/4885KDM4E 646/4885GMNN 382/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.